![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 37, 34161-34167, September 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, June 6, 2002, and in revised form, June 27, 2002
Directed enzyme evolution of 2-hydroxybiphenyl
3-monooxygenase (HbpA; EC 1.14.13.44) from Pseudomonas
azelaica HBP1 resulted in an enzyme variant
(HbpAind) that hydroxylates indole and indole derivatives
such as hydroxyindoles and 5-bromoindole. The wild-type protein does
not catalyze these reactions. HbpAind contains amino acid
substitutions D222V and V368A. The activity for indole hydroxylation was increased 18-fold in this variant. Concomitantly, the
Kd value for indole decreased from 1.5 mM to 78 µM. Investigation of the major
reaction products of HbpAind with indole revealed hydroxylation at the carbons of the pyrrole ring of the substrate. Subsequent enzyme-independent condensation and oxidation of the reaction products led to the formation of indigo and indirubin. The
activity of the HbpAind mutant monooxygenase for the
natural substrate 2-hydroxybiphenyl was six times lower than that of
the wild-type enzyme. In HbpAind, there was significantly
increased uncoupling of NADH oxidation from
2-hydroxybiphenyl hydroxylation, which could be attributed to the
substitution D222V. The position of Asp222 in HbpA, the
chemical properties of this residue, and the effects of its
substitution indicate that Asp222 is involved in substrate
activation in HbpA.
Indole is produced from the aromatic amino acid tryptophan in
tryptophanase-synthesizing bacteria such as Escherichia coli (1). Enzymes that oxygenate the indole pyrrole ring are easily detectable because the reaction products are unstable and form pigments. This observation was first made when the naphthalene oxidation genes were expressed in E. coli, which resulted in
the biosynthesis of indigo (2). Based on these results and because of
its importance as a dye, the biocatalytic production of indigo by
naphthalene dioxygenase was for some time a major goal of the biotech
industry (3, 4).
Naphthalene dioxygenase was soon found not to be the only enzyme
capable of indole oxidation: several other oxygenases that accept
indole as a substrate have been identified (5-10). These are either
enzymes similar to naphthalene dioxygenase that activate oxygen with
iron centers or members of the cytochrome P450 family (6, 11). Although
flavin nucleotides may be involved in electron transfer from cofactors
in these proteins, none is known to be a flavoprotein oxygenase.
This situation has changed with our recent finding that flavosystem
oxygenases can be modified to accept unnatural substrates. 2-Hydroxybiphenyl 3-monooxygenase (HbpA; EC 1.14.13.44) from Pseudomonas azelaica HBP1 is a flavoprotein aromatic
hydroxylase that catalyzes the hydroxylation of a variety of
2-substituted phenols to the corresponding catechols (12-14). The
mechanism of HbpA has been extensively studied by spectroscopic
techniques, which revealed that molecular oxygen is activated via the
formation of a flavin (C4a)-hydroperoxide (15), a
common intermediate in the reaction cycle of this enzyme family (16). HbpA has a broad substrate spectrum, but does not hydroxylate indole
(13, 17). By directed enzyme evolution, we recently changed the
substrate reactivity of HbpA toward 2-tert-butylphenol, a
substrate that is not converted by the wild-type enzyme (18, 19). As a
side product of this work, we also obtained an HbpA variant (which we
denoted HbpAind) with activity for the hydroxylation of indole.
In this study, we report the characterization of HbpAind
with respect to its catalytic properties. Whereas previous work on indole-oxygenating enzymes was mainly aimed at the biotechnological production of indigo, we were especially interested in the formation of
the by-product indirubin. Indirubin and its analogs have been identified as potent inhibitors of cyclin-dependent kinases
(20). The crystal structure of cyclin-dependent kinase-2 in
complex with indirubin derivatives showed that indirubin binds to the kinase ATP-binding site. As a consequence, it inhibits the
proliferation of a wide range of cells and belongs to a group of novel
anticancer compounds that act on the cell cycle (21).
Chemicals, Strains, and Plasmids
Escherichia coli JM101 (22) and the pUC18 plasmid
(23) were used throughout for cloning and expression of the
hbpA gene. Alkaline phosphatase (EC 3.1.3.1) was purchased
from Roche Molecular Biochemicals (Basel, Switzerland). Catalase (EC
1.11.1.6) from beef liver and formate dehydrogenase (EC 1.2.1.2) from
Candida boidinii were obtained from Fluka AG (Buchs,
Switzerland). 4- and 5-hydroxyindole were from ICN Biomedicals Inc.
(Aurora, OH). Components for the complex medium were obtained
from Difco. All other chemicals were of the purest available quality
and obtained from Fluka AG.
Directed Evolution of HbpA
Directed evolution of HbpA was performed by error-prone PCR
based on in vitro manganese mutagenesis as described earlier
(18). The mutant library was subsequently plated onto LB medium. Cells harboring enzymes with activity for the hydroxylation of indole formed
deep blue colonies. The single mutant D222V
(HbpAD222V) was constructed using the
QuickChangeTM site-directed mutagenesis kit from Stratagene
(La Jolla, CA).
Protein Synthesis and Purification
Synthesis of wild-type HbpA and HbpAind was done in
recombinant E. coli JM101 using M9 mineral medium and
glycerol as the carbon source (17). After harvesting the cells, the
proteins were purified according to the method described recently
(18).
Analytical Methods
Determination of Activity for 2-Hydroxybiphenyl--
The
activity of wild-type HbpA and HbpAind was determined by
measuring substrate consumption and product formation with
reverse-phase high pressure liquid chromatography
(HPLC)1 as described
elsewhere (24). The assay contained 0.2 µM HbpA or
variant protein, 0.3 mM NADH, 0.2 mM
2-hydroxybiphenyl, and 20 mM air-saturated phosphate buffer
(pH 7.5).
Determination of in Vivo Indigo Formation--
The activity of
recombinant E. coli JM101 for the formation of indigo was
determined in 250-ml shaking flasks containing 50 ml of LB medium (22).
Cultures of E. coli JM101 cells harboring a pUC18 derivative
encoding HbpA or HbpAind were inoculated to A450 = 0.1. The cultures were incubated at
30 °C and vigorously shaken. When the culture color turned olive,
samples of 1.1 ml were taken. 100 µl of these were used to determine
the cell dry weight at 450 nm (25). The remaining 1 ml was centrifuged,
and the supernatant was carefully removed. Cell-associated indigo was
extracted with N,N-dimethylformamide (DMF) and
quantified at 610 nm ( Determination of in Vitro Indigo Formation--
The activity for
indole was determined using an assay with NADH regeneration by formate
dehydrogenase from C. boidinii (Fig. 1) (26). The assay contained 0.2 µM HbpA or variant, 0.25 units of formate dehydrogenase,
160 mM sodium formate, 10 units of catalase from beef
liver, 0.3 mM NADH, and 2 mM indole in 1 ml of
50 mM sodium phosphate buffer (pH 7.5). The assay was
stopped by the addition of 20 µl of 10% (v/v) perchloric acid, and
the precipitated proteins were spun down. The pellet- and
tube-associated indigo was extracted with DMF and
spectrophotometrically quantified.
Determination of Dissociation Constants--
Dissociation
constants between the enzymes and substrates were determined by
monitoring the absorption changes of the enzyme-bound FAD upon binding
of substrate (27). For this, 12 µM purified wild-type
HbpA and HbpAind were titrated with known concentrations of
2-hydroxybiphenyl or indole, and the resulting spectra were recorded
using a Varian Cary E1 UV-visible spectrophotometer. Plotting HPLC-Mass Spectroscopy (MS) Analysis--
Analysis of compounds
formed during in vitro indigo assays was done by
reverse-phase HPLC-MS (Hewlett Packard 1100 MSD). The compounds were
separated on a Hypersil ODS column (5 µm, 4.5 × 125 mm) and
detected with a diode array detector and a mass spectrometer. Acidified
(0.1% formic acid) H2O (solvent A) and 50% methanol and
50% acetonitrile (solvent B) were applied as the mobile phase according to the following timetable: 0 to 8 min, 85:15 solvent A/solvent B, flow rate of 1 ml min TLC Analysis--
The formed pigments were analyzed by TLC using
silica gel cards and either toluene/acetone (4:1) or chloroform/acetone
(97:3) as the mobile phase (28).
Electron Microscopy--
For ultrathin sectioning, cells were
fixed in 2.5% glutaraldehyde for 60 min and subsequently washed with
water and embedded in low-melting-point agarose. After fixation in 1%
OsO4 for 60 min, the blocks were dehydrated with ethanol
and acetone and embedded in Epon/Araldite (29). Sections cut from the
Epon/Araldite preparation were contrasted with uranyl acetate and lead citrate.
Freeze-fracturing was carried out following standard procedures using a
Balzers BAF 300 apparatus. The specimen sandwiches were fractured at
Directed Evolution of HbpA
We recently changed the substrate reactivity of 2-hydroxybiphenyl
3-monooxygenase (HbpA) from P. azelaica HBP1 by directed evolution (18). This work led to a mutant monooxygenase with increased
activity for the hydroxylation of indole. The HbpA variant was denoted
HbpAind. E. coli JM101 cultures synthesizing
HbpAind turned deep blue when grown overnight on LB medium.
Electron microscopy revealed the extracellular accumulation of
material, which, we believe, consists of the water-insoluble pigment.
After centrifugation, the pigment was extracted from the pellet with
DMF. It was authenticated as indigo by TLC with toluene/acetone (4:1)
as the mobile phase and commercially available indigo as the standard.
This analysis also revealed the presence of a major by-product. The
RF value of this red pigment corresponded to the
RF value determined earlier for indirubin (28).
Analysis by HPLC-MS with 70% (v/v) methanol as the mobile phase showed
two prominent molecular ion (MH+) peaks at m/z
263 with retention times of 3.7 and 4.2 min. The UV-visible spectra and
the fragmentation patterns were compared with literature data (28, 30,
31), which confirmed that these two compounds were indigo (3.7 min) and
indirubin (4.2 min).
The formation of indigo by recombinant E. coli JM101 cells
growing on LB medium was quantified. Cultures expressing the
hbpAind gene accumulated 150 µM indigo
within 8 h, whereas cultures of the host synthesizing HbpA
remained colorless (Fig. 2). Recombinant protein levels in both cultures were checked by SDS-PAGE, and HbpA
levels were determined to be in the same range of ~20% of total cell
protein.
Stability of Biotechnologically Produced Indigo
When pigments were extracted with DMF from recombinant E. coli JM101 cultures, the extract had a deep blue color. The blue color disappeared upon storage at room temperature, and the solution turned red (Fig. 3). The red pigment was
analyzed by UV-visible spectroscopy, HPLC-MS, and TLC. It was
authenticated as indirubin by comparison of the obtained results with
literature data (28, 30, 31). Buffering the pH at a value of 7 or
acidification with 0.1% (v/v) 10 M hydrochloric acid
stabilized the formed indigo, whereas the addition of 0.1% (v/v) 10 M sodium hydroxide or heating accelerated the disappearance
of the blue color.
Hydroxylation of Indole by Laboratory-evolved
2-Hydroxybiphenyl 3-Monooxygenase*
,
,
,
¶
Institute of Biotechnology, Swiss Federal
Institute of Technology (ETH) Zurich, ETH Hönggerberg-HPT,
CH-8093 Zürich, Switzerland and § Environmental
Microbiology and Molecular Ecotoxicology, Swiss Federal Institute
of Environmental Sciences and Technology,
CH-8600 Dübendorf, Switzerland
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
610 = 15,900 liters
mol
1 cm
1) (8).

View larger version (9K):
[in a new window]
Fig. 1.
Scheme of in vitro indigo
formation assay. HbpA, 2-hydroxybiphenyl
3-monooxygenase or HbpAind; FDH, formate
dehydrogenase.
absorbance at a specific wavelength allowed the calculation of the
dissociation constants by weighted nonlinear regression analysis
(Enzfitter, Elsevier-Biosoft, Cambridge, U. K.).
1; gradient to 10 min,
to 65:35 solvent A/solvent B, flow rate of 2 ml min
1; to
15 min, 65:35 solvent A/solvent B, flow rate of 2 ml
min
1. Standards for isatin, 4- and 5-hydroxyindole,
2-indolinone, and indole were commercially available. 3-Indoxyl was
prepared by dephosphorylating 3-indoxyl phosphate with alkaline
phosphatase under anaerobic conditions. HPLC-MS analysis of the formed
pigments was done under isocratic conditions at a flow rate of 1 ml
min
1 with 70% (v/v) methanol as the mobile phase for the
pigments derived from indole and with 40% (v/v) methanol for those
derived from 4- and 5-hydroxyindole.
150 °C and immediately replicated with platinum/carbon. All
pictures were taken with a Philips EM301 electron microscope.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 2.
In vivo indigo formation by HbpA
and HbpAind. Shown is the formation of indigo during
growth of recombinant E. coli JM101 cells on LB medium
synthesizing wild-type HbpA or HbpAind. Symbols for cell
dry weight (CDW) are as follows:
, wild-type HbpA; and
, HbpAind. Symbols for indigo concentration are as
follows:
, wild-type HbpA; and
, HbpAind.

View larger version (65K):
[in a new window]
Fig. 3.
Indigo and indirubin. Shown is
indigo freshly extracted from a recombinant E. coli culture
(right) and after incubation at room temperature for 72 h (left).
General Properties of HbpAind
The mutant monooxygenase HbpAind differs from wild-type HbpA by two amino acids: Asp222 was substituted by valine, and Val368 was substituted by alanine. HbpAind was purified according to the procedure developed for the wild-type enzyme with a yield of ~30%. Analytical size-exclusion chromatography showed that the mutant monooxygenase formed a tetramer, which is also the case for wild-type HbpA (14).
Major Reaction Products of Indole Hydroxylation by HbpAind
To identify the major reaction products of indole hydroxylation, in vitro indigo formation assays were performed. After 30 min, a sample was taken and immediately saturated with argon. The proteins were precipitated and separated by centrifugation. The pigments in the pellet were extracted with DMF and analyzed by TLC. They were identified as indigo and indirubin. Analysis of the aqueous phase by HPLC-MS revealed the presence of 3-hydroxyindole (indoxyl) and 2-indolinone (oxindole). When a sample was taken after 60 min of assay time, isatin was also detected (Table I).
|
Substrate Spectrum of HbpAind
To investigate the substrate range of the HbpAind mutant monooxygenase, in vitro assays were performed with 4- and 5-hydroxyindole and 5-bromoindole. For the variant enzyme, color formation could be observed with all substrates, whereas the control assays with the wild-type protein remained colorless. The pigment derived from 4-hydroxyindole was purple, that from 5-hydroxyindole was orange, and that from 5-bromoindole was pink.
The polar reaction products of the assays with 4- and 5-hydroxyindole were analyzed by HPLC-MS. For this, the in vitro assay was stopped by the addition of perchloric acid, and the proteins were spun down. Mass peaks (MH+) at m/z 150 were detected in the supernatants from both reactions. This mass correlates with the single hydroxylated substrates. The corresponding compounds eluted between 4.5 and 6.5 min when using 40% (v/v) methanol as the mobile phase. The main condensation products had a prominent molecular ion peak (MH+) at m/z 279 and had retention times of 4.1 min for the assay with 4-hydroxyindole and 3.5 min for the assay with the 5-substituted isomer. UV-visible spectra showed the peak at 4.1 min to have a maximum at 494 nm, whereas the peak at 3.5 min had a maximum at 480 nm. Thus, the molecular mass and the spectral properties indicated that the dihydroxy derivatives of indoxyl red were formed (see Fig. 7).
Catalytic Properties of HbpA and HbpAind
Specific Activities for 2-Hydroxybiphenyl and Indole--
The
in vitro activity of the purified proteins for the natural
substrate 2-hydroxybiphenyl was determined by measuring substrate consumption and product formation by reverse-phase HPLC. The
kcat of HbpAind was significantly
lower than that of the wild-type enzyme (Table
II). Indole hydroxylation activities were
determined in assays with purified proteins and NADH regeneration by
formate dehydrogenase from C. boidinii. The assay mixture
containing the mutant monooxygenase showed a blue color within the
first 30 min, whereas the assay mixture with the wild-type enzyme
remained white. HbpAind formed up to 170 µM
indigo, whereas hardly any indigo formation could be observed for HbpA
(Fig. 4). The indole hydroxylation activity of HbpAind was ~20 milliunits mg
1
purified protein or ~18 times higher than the corresponding value for
the wild-type enzyme.
|
|
Equilibrium Binding of Substrates to HbpA and
HbpAind--
The affinities of the enzymes for
2-hydroxybiphenyl and indole were determined by titration of the
purified proteins with known concentrations of substrate (Fig.
5, insets). Plotting the absorption difference at a specific wavelength as a function of substrate concentration (Fig. 5) allowed the determination of the
Kd values. Whereas the dissociation constants for 2-hydroxybiphenyl were in the same range for both proteins, the Kd value for indole was 20-fold lower for
HbpAind than for HbpA (Table II).
|
Uncoupling of NADH Oxidation from 2-Hydroxybiphenyl Hydroxylation-- Wild-type HbpA shows an uncoupling of NADH oxidation from 2-hydroxybiphenyl hydroxylation of 21% (18). Substitution of a single amino acid (V368A in HbpAT1) completely coupled these two reactions (18). In contrast, there was significant uncoupling of NADH oxidation from hydroxylation for HbpAind compared with HbpA and HbpAT1 (Table III). To investigate whether the increased uncoupling in HbpAind is an effect of the combination of the two amino acid substitutions or only due to the D222V exchange, the single mutant D222V (HbpAD222V) was constructed by site-directed mutagenesis. Uncoupling of NADH oxidation from 2-hydroxybiphenyl hydroxylation was 3-fold higher for the HbpAD222V mutant monooxygenase than for the wild-type protein (Table III).
|
| |
DISCUSSION |
|---|
|
|
|---|
Hydroxylation of Indole by HbpAind-- Indole is oxidized by different oxygenases that contain either protein-bound iron or cytochrome to activate molecular oxygen (6, 32). No flavoprotein oxygenase has thus far been shown to accept indole as a substrate. A 2-hydroxybiphenyl 3-monooxygenase variant (HbpAind), which we obtained during directed evolution of HbpA, showed the ability to hydroxylate indole. The kcat/Kd of HbpAind for indole was 330-fold higher than that of wild-type HbpA and is in the same order as the catalytic efficiency determined for the engineered fatty-acid hydroxylase P450 BM-3 (33). This P450 variant was obtained by saturation mutagenesis and is the enzyme with the highest known catalytic efficiency for indole.
Cultures of E. coli JM101 cells that synthesized
HbpAind during growth on LB medium had an indigo
productivity of ~5 mg liter
1 h
1. In
comparison, a recombinant E. coli HB101 culture that
expressed the naphthalene dioxygenase genes produced ~1 mg
liter
1 h
1 during growth on the same medium
to a similar cell density (2). E. coli cultures that
synthesized human P450 cytochromes reached productivities of ~0.3 mg
liter
1 h
1 on fortified terrific
broth (TB) medium (6). Thus, the HbpAind flavoprotein
recombinant is considerably (5-15-fold) more active in vivo
in the formation of indigo from complex medium. Analysis of the
pigments formed also showed the presence of the by-product indirubin, a
structural isomer of indigo that is known to be formed by
indole-oxidizing enzymes (4, 10).
Indigo extracted from recombinant E. coli cultures showed only limited stability when stored in DMF at room temperature. This could be attributed to the pH of the solution. It is known from denim manufacturing that at basic pH indigo is chemically reduced to its water-soluble form, indigo white. In contrast, the formed indirubin was stable when extracted and stored in DMF.
Major Reaction Products of Indole Hydroxylation--
The products
of indole oxidation by different mono- and dioxygenases have been
investigated. Indole epoxide has been suggested as a product of the
reaction catalyzed by styrene monooxygenase (7), and indoxyl
(3-hydroxyindole) has been identified as a hydroxylation product of
cytochrome P450 enzymes (6). Oxidation by naphthalene dioxygenase
results in the formation of 2,3-dihydroxy-2,3-dihydroindole (2). All
these reaction products are unstable and spontaneously form pigments.
The identification of the intermediates formed during in
vitro indigo assays with HbpAind suggests a similar route as observed for the P450 enzymes (Fig.
6). The identification of 3-hydroxyindole
and 2-indolinone indicates direct hydroxylation at the carbons of the
pyrrole ring of indole. In contrast to the P450 enzymes, no
hydroxylation at the benzene ring of the substrate was observed (6).
The presence of isatin could have two origins: it was produced either
by hydroxylation of indoxyl or oxindole or by the decomposition of
indigo and indirubin. The formation of indigo and indirubin from the
enzymatic hydroxylation products of indole is spontaneous and
biocatalyst-independent. In short, condensation of two molecules of
indoxyl followed by air oxidation leads to the production of indigo,
whereas condensation of indoxyl and 2-indolinone yields indirubin (28,
34). In addition, indirubin can also be formed by the reaction of
indoxyl with isatin (4, 35). That this latter reaction does indeed take
place in the case of indirubin formation by HbpAind is
supported by the fact that the ratio of indirubin to indigo increased
with time when recombinant E. coli cells were grown on LB
medium.
|
Substrate Spectrum of HbpAind--
Indirubin inhibits
cyclin-dependent kinases and therefore belongs to a group
of promising anticancer compounds (20). Analogs such as indirubin
3'-monoxime and halogenated indirubins show even higher potency (36).
This increased biological activity can be attributed to the lower
hydrophobicity of the derivatives compared to indirubin. Thus, the
uptake of the compound is facilitated and the probability that it
reaches the biological sites of action is increased (37). In this
context, we investigated the substrate spectrum of HbpAind.
The variant showed activity with several indole derivatives such as 4- and 5-hydroxyindole. The products of these reactions are potentially
interesting because their log P values are significantly
different from that of the unsubstituted indirubin and are hardly
accessible by chemical means. However, analysis of the formed pigments
showed that the dihydroxyindirubin derivatives were only a minor
product of the reaction of HbpAind with hydroxyindoles. The
mass and the spectral properties of the major condensation product
indicated that mainly the indoxyl red derivatives were formed. Indoxyl
red is known to be formed from the reaction of
3-oxo-3H-indole with indole (38). The proposed pathway for
the formation of the dihydroxy derivatives by HbpAind from
hydroxyindole is shown in Fig. 7. The
electron-donating hydroxyl group at the benzene ring facilitates the
oxidation of the indolinone compared with the unsubstituted compound
and may explain why indoxyl red was not detected from the reaction of
HbpAind with indole. Indoxyl red shares a high degree of
structural similarities with indirubin. The dihydroxy derivatives have
a strongly decreased hydrophobicity, and their potency in inhibiting
cyclin-dependent kinases is worth investigating.
|
Catalytic Properties of HbpAind--
We characterized
HbpAind with respect to its catalytic properties. The
variant's activity for indole was increased by ~18-fold compared
with the wild-type enzyme. This increase was concomitant with an
enhanced affinity of the enzyme for this substrate. The in
vitro activity of the mutant monooxygenase for the natural substrate 2-hydroxybiphenyl was significantly decreased, whereas its
affinity for this substrate remained unchanged. This is mostly due to a
slower flavin reduction, as indicated by the reduced NADH oxidation
rate. In addition, uncoupling of NADH oxidation from substrate
hydroxylation was significantly increased in HbpAind. HbpAind evolved from the single mutant V368A
(HbpAT1) by directed enzyme evolution. In contrast to
wild-type HbpA, HbpAT1 fully couples NADH oxidation to
2-hydroxybiphenyl hydroxylation. We have suggested that this is due to
the stabilization and/or improved positioning of the flavin
(C4a)-hydroperoxide toward the substrate (18). This enhanced
hydroxylation efficiency was completely destroyed by the D222V
substitution: in HbpAind, the uncoupling was twice that of
the wild-type protein with 2-hydroxybiphenyl as substrate, whereas the
unproductive NADH oxidation rate was similar in both enzymes. The
single mutant HbpAD222V even showed a 3-fold increased
uncoupling, which was concomitant with a 3-fold increased unproductive
NADH oxidation rate. Thus, the substitution D222V in
HbpAind and HbpAD222V directly increased the
ratio of flavin (C4a)-hydroperoxide decay to 2,3-dihydroxybiphenyl
formation (Fig. 8). This ratio is
primarily influenced by stabilization of the flavin
(C4a)-hydroperoxide, solvent access to the active site, and the
reactivity of the substrate toward electrophilic attack by the terminal
oxygen of the peroxide. According to the structural model of HbpA (18),
Asp222 is located close to the bound substrate in the
substrate-binding domain. Interestingly, Asp222 of HbpA
corresponds to Tyr201 of p-hydroxybenzoate
hydroxylase from Pseudomonas fluorescens (39, 40). In
p-hydroxybenzoate hydroxylase, Tyr201 is
critically involved in the ionization of the substrate, thus affecting
flavin movement and allowing efficient hydroxylation (41, 42). The
substitution Y201F results in an increased uncoupling of NADH oxidation
from substrate hydroxylation up to 95% (43). In phenol 2-monooxygenase
from Trichosporon cutaneum, Tyr289 is
hydrogen-bonded with the hydroxyl group of the substrate, comparable to
Tyr201 in p-hydroxybenzoate hydroxylase (44).
Substitution of this residue by Phe increased the uncoupling from 10 to
34% (45). With respect to the localization of Asp222 in
the HbpA model, the chemical properties of this residue, and the
effects resulting from its substitution, it is likely that Asp222 plays a similar role in HbpA as do the tyrosine
residues in p-hydroxybenzoate hydroxylase and phenol
2-monooxygenase.
|
In summary, we characterized the HbpAind mutant
monooxygenase, the first flavoprotein able to hydroxylate indole. These
investigations point to the importance of Asp222 in the
catalytic cycle of HbpA. Thus, the results obtained here may serve as
the basis for further elucidation of the mechanism of substrate
activation in this enzyme.
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. E. Wehrli (ETH Zurich) for performing the electron microscopy.
| |
FOOTNOTES |
|---|
* This work was supported by Swiss National Science Foundation Grant 5002-046098.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 41-1-6333286; Fax: 41-1-6331051; E-mail: bw@biotech.biol.ethz.ch.
Published, JBC Papers in Press, July 8, 2002, DOI 10.1074/jbc.M205621200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HPLC, high pressure liquid chromatography; DMF, N,N-dimethylformamide; MS, mass spectroscopy.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
DeMoss, R. D.,
and Moser, K.
(1969)
J. Bacteriol.
98,
167-171 |
| 2. |
Ensley, B. D.,
Ratzkin, B. J.,
Osslund, T. D.,
Simon, M. J.,
Wackett, L. P.,
and Gibson, D. T.
(1983)
Science
222,
167-169 |
| 3. | Murdock, D., Ensley, B. D., Serdar, C., and Thalen, M. (1993) Bio/Technology 11, 381-386 |
| 4. | Bialy, H. (1997) Nat. Biotechnol. 15, 110[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Bhushan, B., Samanta, S. K., and Jain, R. K. (2000) Lett. Appl. Microbiol. 31, 5-9[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Gillam, E. M. J., Notley, L. M., Cai, H., de Voss, J. J., and Guengerich, F. P. (2000) Biochemistry 39, 13817-13824[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | O'Connor, K. E., Dobson, A. D. W., and Hartmans, S. (1997) Appl. Environ. Microbiol. 63, 4287-4291[Abstract] |
| 8. | O'Connor, K. E., and Hartmans, S. (1998) Biotechnol. Lett. 20, 219-223[CrossRef] |
| 9. |
Panke, S.,
Witholt, B.,
Schmid, A.,
and Wubbolts, M. G.
(1998)
Appl. Environ. Microbiol.
64,
2032-2043 |
| 10. | Hart, S., Koch, K. R., and Woods, D. R. (1992) J. Gen. Microbiol. 138, 211-216[Medline] [Order article via Infotrieve] |
| 11. |
Ensley, B. D.,
and Gibson, D. T.
(1983)
J. Bacteriol.
155,
505-511 |
| 12. | Eppink, M. H. M., Schreuder, H. A., and van Berkel, W. J. H. (1997) Protein Sci. 6, 2454-2458[Abstract] |
| 13. |
Kohler, H.-P. E.,
Kohler-Staub, D.,
and Focht, D. D.
(1988)
Appl. Environ. Microbiol.
54,
2683-2688 |
| 14. |
Suske, W. A.,
Held, M.,
Schmid, A.,
Fleischmann, T.,
Wubbolts, M. G.,
and Kohler, H.-P. E.
(1997)
J. Biol. Chem.
272,
24257-24265 |
| 15. |
Suske, W. A.,
van Berkel, W. J. H.,
and Kohler, H.-P. E.
(1999)
J. Biol. Chem.
274,
33355-33365 |
| 16. | van Berkel, W. J. H., Eppink, M. H. M., van der Bolt, F. J. T., Vervoort, J., Rietjens, I. M. C. M., and Schreuder, H. A. (1997) in Flavins and Flavoproteins (Stevenson, K. J. , Massey, V. , and Williams, C. H., Jr., eds) , pp. 305-314, University of Calgary Press, Calgary, Canada |
| 17. | Held, M., Suske, W., Schmid, A., Engesser, K.-H., Kohler, H.-P. E., Witholt, B., and Wubbolts, M. G. (1998) J. Mol. Catal. B 5, 87-93 |
| 18. |
Meyer, A.,
Schmid, A.,
Held, M.,
Westphal, A. H.,
Röthlisberger, M.,
Kohler, H.-P. E.,
van Berkel, W. J. H.,
and Witholt, B.
(2002)
J. Biol. Chem.
277,
5575-5582 |
| 19. | Meyer, A., Held, M., Schmid, A., Kohler, H.-P. E., and Witholt, B. (2002) Biotechnol. Bioeng., in press |
| 20. | Hoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., Niederberger, E., Tang, W., Eisenbrand, G., and Meijer, L. (1999) Nat. Cell Biol. 1, 60-67[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Buolamwini, J. K. (2000) Curr. Pharm. Des. 6, 379-392[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, New York |
| 23. | Yanish-Perron, C., Vieira, J., and Messing, J. (1985) Gene (Amst.) 33, 103-109[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Kohler, H.-P. E.,
Schmid, A.,
and van der Maarel, M.
(1993)
J. Bacteriol.
175,
1621-1628 |
| 25. |
Witholt, B.
(1972)
J. Bacteriol.
109,
350-364 |
| 26. | Kula, M.-R., and Wandrey, C. (1987) Methods Enzymol. 136, 9-21[Medline] [Order article via Infotrieve] |
| 27. | van Berkel, W., Westphal, A., Eschrich, K., Eppink, M., and de Kok, A. (1992) Eur. J. Biochem. 210, 411-419[Medline] [Order article via Infotrieve] |
| 28. |
Eaton, R. W.,
and Chapman, P. J.
(1995)
J. Bacteriol.
177,
6983-6988 |
| 29. | Hess, W. M. (1966) Stain Technol. 41, 27-35[Medline] [Order article via Infotrieve] |
| 30. | Fearon, W. R., and Boggust, W. A. (1950) Biochem. J. 46, 62-67 |
| 31. | Laatsch, H., and Ludwig-Köhn, H. (1986) Liebigs Ann. Chem. 1847-1853 |
| 32. | Carredano, E., Karlsson, A., Kauppi, B., Choudhury, D., Parales, R. E., Parales, J. V., Lee, K., Gibson, D. T., Eklund, H., and Ramaswamy, S. (2000) J. Mol. Biol. 296, 701-712[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Li, Q.-S., Schwaneberg, U., Fischer, M., and Schmid, R. D. (2000) Chem. Eur. J. 6, 1531-1536[CrossRef] |
| 34. | Russell, G. A., and Kaupp, G. (1969) J. Am. Chem. Soc. 91, 3851-3859[CrossRef] |
| 35. | Maugard, T., Enaud, E., Choisy, P., and Legoy, M. D. (2001) Phytochemistry 58, 897-904[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Marko, D., Schatzle, S., Friedel, A., Genzlinger, A., Zankl, H., Meijer, L., and Eisenbrand, G. (2001) Br. J. Cancer 84, 283-289[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Hansch, C. (1969) Acc. Chem. Res. 2, 232-239[CrossRef] |
| 38. | Capdevielle, P., and Maumy, M. (1993) Tetrahedron Lett. 34, 2953-2956[CrossRef] |
| 39. |
Gatti, D. L.,
Palfey, B. A.,
Lah, M. S.,
Entsch, B.,
Massey, V.,
Ballou, D. P.,
and Ludwig, M. L.
(1994)
Science
266,
110-114 |
| 40. | Schreuder, H. A., Mattevi, A., Obmolova, G., Kalk, K. H., Hol, W. G. J., van der Bolt, F. J. T., and van Berkel, W. J. H. (1994) Biochemistry 33, 10161-10170[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Palfey, B. A., Moran, G. R., Entsch, B., Ballou, D. B., and Massey, V. (1999) Biochemistry 38, 1153-1158[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Gatti, D. L., Entsch, B., Ballou, D. P., and Ludwig, M. L. (1996) Biochemistry 35, 567-578[CrossRef][Medline] [Order article via Infotrieve] |
| 43. |
Entsch, B.,
Palfey, B. A.,
Ballou, D. P.,
and Massey, V.
(1991)
J. Biol. Chem.
266,
17341-17349 |
| 44. | Enroth, C., Neujahr, H., Schneider, G., and Lindqvist, Y. (1998) Structure 6, 605-617[Medline] [Order article via Infotrieve] |
| 45. | Xu, D., Ballou, D. P., and Massey, V. (2001) Biochemistry 40, 12369-12378[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
C. Guan, J. Ju, B. R. Borlee, L. L. Williamson, B. Shen, K. F. Raffa, and J. Handelsman Signal Mimics Derived from a Metagenomic Analysis of the Gypsy Moth Gut Microbiota Appl. Envir. Microbiol., June 1, 2007; 73(11): 3669 - 3676. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Leungsakul, G. R. Johnson, and T. K. Wood Protein Engineering of the 4-Methyl-5-Nitrocatechol Monooxygenase from Burkholderia sp. Strain DNT for Enhanced Degradation of Nitroaromatics. Appl. Envir. Microbiol., June 1, 2006; 72(6): 3933 - 3939. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |